PRODUCT FEATURES
Stent Design
- High radial force with minimum recoil to be able to treat BTK lesions.
- Specifically designed for homogeneous arterial coverage.
Coating technology
- TransferWise, the iVascular proprietary technology that provides a homogenous drug elution that translates into lower rates of restenosis and inflammation score.
- Our fluoro-acrylate polymer provides an early endothelialization and creates a thromboresistant layer.
CLINICAL SUPPORT
Description
- Device: Angiolite BTK
- Number of patients: 50
- Followup: 6months
- Type of Lesions: BTK procedures
Conclusion: The use of Angiolite BTK is safe and feasible. Follow-up needs to confirm advantages of the use of the device. Angiolite BTK has a positive effect on revascularization/wound healing.
Main Investigator: Dr. Peter Goverde Vascular Clinic ZNA (Antwerp, BE)
Description
- Device: Luminor 14m & Angiolite BTK as bailout stenting
- Number of patients: 50
- Followup: 2 years
- Type of Lesions: Long tibial occlusive lesions TASC C&D
Luminor DCB is safe and efficacious, in treating highly complex infra-popliteal atherosclerotic lesions in challenging CLTI patients. Luminor is associated with highly satisfactory acute technical success, 6-month target lesion patency and AFS.
Main Investigator: Dr T. Tang, General Hospital (Singapore)